The use of a pramipexole transdermal patch has been associated with the downregulation of APAF1 in the 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated PD mouse model [39]. This evidence concerns the gene APAF1 and Parkinson disease.